Herzog, Roland W.

Reprogrammed CD4+ T Cells That Express FoxP3+ Control Inhibitory Antibody Formation in Hemophilia A Mice

Herzog, R. W., Kuteyeva, V., Saboungi, R., Terhorst, C., & Biswas, M. (2019) · Frontiers in Immunology

Hemophilia Treatment and ResearchT-cell and B-cell Immunology

Cited by 24

Liver Gene Therapy: Reliable and Durable

Herzog, R. W., & Pierce, G. F. (2019) · Molecular Therapy

Virus-based gene therapy researchHemophilia Treatment and Research

Cited by 23

An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8+ T Cells

Palaschak, B., Marsic, D., Herzog, R. W., Zolotukhin, S., & Markusic, D. M. (2017) · Molecular Therapy - Methods & Clinical Development

Virus-based gene therapy researchHemophilia Treatment and Research

Cited by 19

Encouraging and Unsettling Findings in Long-Term Follow-up of AAV Gene Transfer

Herzog, R. W. (2020) · Molecular Therapy

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 18

Distortion of journal impact factors in the era of paper mills

Bricker-Anthony, C., & Herzog, R. W. (2023) · Molecular Therapy

scientometrics and bibliometrics researchAcademic Writing and Publishing

Cited by 16

Addressing the big business of fake science

Frederickson, R. M., & Herzog, R. W. (2022) · Molecular Therapy

Academic integrity and plagiarismAcademic Publishing and Open Access

Cited by 16

A Cure For Hemophilia: the Promise Becomes a Reality

Herzog, R. W. (2016) · Molecular Therapy

Hemophilia Treatment and ResearchVirus-based gene therapy research

Cited by 15

Keeping them honest: fighting fraud in academic publishing

Frederickson, R. M., & Herzog, R. W. (2021) · Molecular Therapy

Academic integrity and plagiarismPublishing and Scholarly Communication

Cited by 13

AAV Vector Dose Determines TLR9 Dependence of CD8+ T Cell Response to Transgene Product

Li, N., Bertolini, T., & Herzog, R. W. (2020) · Blood

Virus-based gene therapy researchImmunotherapy and Immune Responses

Cited by 5